These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 31526550)
1. Cancer and the Immune System: The History and Background of Immunotherapy. Abbott M; Ustoyev Y Semin Oncol Nurs; 2019 Oct; 35(5):150923. PubMed ID: 31526550 [TBL] [Abstract][Full Text] [Related]
2. Considerations for successful cancer immunotherapy in aged hosts. Hurez V; Padrón Á; Svatek RS; Curiel TJ Exp Gerontol; 2018 Jul; 107():27-36. PubMed ID: 28987644 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Pediatric Oncology: An Overview of Therapy Types and Nursing Implications. Warren CB Clin J Oncol Nurs; 2018 Dec; 22(6):649-655. PubMed ID: 30452014 [TBL] [Abstract][Full Text] [Related]
4. The Future of Immunotherapy in the Treatment of Cancer. Kottschade LA Semin Oncol Nurs; 2019 Oct; 35(5):150934. PubMed ID: 31477413 [TBL] [Abstract][Full Text] [Related]
5. In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy. Kumar H; Bot A Int Rev Immunol; 2017 Jul; 36(4):205-206. PubMed ID: 28537793 [No Abstract] [Full Text] [Related]
6. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles. Zhang M; Kim JA; Huang AY Front Immunol; 2018; 9():341. PubMed ID: 29535722 [TBL] [Abstract][Full Text] [Related]
7. Patient education resources related to biotherapy and the immune system. Straw LJ; Conrad KJ Oncol Nurs Forum; 1994 Aug; 21(7):1223-8. PubMed ID: 7971432 [TBL] [Abstract][Full Text] [Related]
10. Role of Clinical Pharmacology in the Development and Approval of Immunotherapies Targeting Immune Checkpoints. Rahman A Clin Pharmacol Ther; 2016 Dec; 100(6):591-593. PubMed ID: 27500894 [TBL] [Abstract][Full Text] [Related]
11. Novel approaches in cancer immunotherapy -- a light at the end of the tunnel. Joshi M; Pal SK; Drabick JJ Discov Med; 2016 Jun; 21(118):479-87. PubMed ID: 27448784 [TBL] [Abstract][Full Text] [Related]
12. [The biological rationale for immunotherapy in cancer]. Benzaquen J; Marquette CH; Glaichenhaus N; Leroy S; Hofman P; Ilié M Rev Mal Respir; 2018 Feb; 35(2):206-222. PubMed ID: 29428191 [TBL] [Abstract][Full Text] [Related]
13. Overview of Basic Immunology for Clinical Investigators. Stephen B; Hajjar J Adv Exp Med Biol; 2017; 995():1-31. PubMed ID: 28321810 [TBL] [Abstract][Full Text] [Related]
14. The importance of correctly timing cancer immunotherapy. Beyranvand Nejad E; Welters MJ; Arens R; van der Burg SH Expert Opin Biol Ther; 2017 Jan; 17(1):87-103. PubMed ID: 27802061 [TBL] [Abstract][Full Text] [Related]
15. T cell tolerance to tumors and cancer immunotherapy. Shafer-Weaver K; Anderson M; Malyguine A; Hurwitz AA Adv Exp Med Biol; 2007; 601():357-68. PubMed ID: 17713024 [TBL] [Abstract][Full Text] [Related]
16. Patient Education Issues and Strategies Associated With Immunotherapy. Lasa-Blandon M; Stasi K; Hehir A; Fischer-Cartlidge E Semin Oncol Nurs; 2019 Oct; 35(5):150933. PubMed ID: 31481275 [TBL] [Abstract][Full Text] [Related]
17. [Breaking immune tolerance in cancer]. Desbois M; Champiat S; Chaput N Bull Cancer; 2015 Jan; 102(1):34-52. PubMed ID: 25609492 [TBL] [Abstract][Full Text] [Related]